| 图片 | 名称及描述 | |
|---|---|---|
|
β-D-allo-Heptofuranoadenosine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-(2-methoxyethyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
|
|
β-D-allo-Octofuranuronic acid, 3,7-anhydro-1,5,6-trideoxy-1-(3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-, methyl ester (9CI)
97%
|
|
|
α-L-Lyxofuranuronic acid, 1-deoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-, methyl ester, 2-(O-phenyl carbonothioate) (ACI)
97%
|
|
|
β-D-Glucofuranuronic acid, 1-deoxy-1-(4-methoxy-2-oxo-1(2H)-pyrimidinyl)-, methyl ester, 2-acetate 5-benzoate (ACI)
97%
|
|
|
β-D-Ribofuranuronamide, 1-[6-amino-2-[(2-hydroxybicyclo[2.2.1]hept-2-yl)ethynyl]-9H-purin-9-yl]-N-cyclopropyl-1-deoxy- (9CI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(β-phenylbenzenepropanoate) (9CI)
97%
|
|
|
β-D-Ribofuranuronic acid, 1-(6-amino-9H-purin-9-yl)-1-deoxy-, methyl ester, 2-acetate (9CI, ACI)
97%
|
|
|
2'-Deoxy-L-adenosine
98%
|
|
|
2,4-dihydroxypyrimidine-5-carbaldehyde
97%
|
|
|
β-D-allo-Heptofuranoadenosine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
|
|
β-D-allo-Octofuranouridine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-5-methyl-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
|
|
α,α,α-Trifluoro-3-[(8-heptadecen-1-yloxy)carbonyl]thymidine (ACI)
97%
|
|
|
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(11Z)-11-eicosenoate (9CI)
97%
|
|
|
α-[(4-Hydroxybenzoyl)amino]thymidine 5′-(tetrahydrogen triphosphate) (ACI)
97%
|
|
|
β-D-Ribofuranuronic acid, 1-(6-amino-9H-purin-9-yl)-1,3-dideoxy-3-[[O-methyl-N-[N-[(phenylmethoxy)carbonyl]glycyl]-L-tyrosyl]amino]- (9CI)
97%
|
|
|
β-D-ribo-Heptofuranothymidine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′,6′-dideoxy-2′-fluoro-β-D-altrofuranoguanylyl-(3′→5′-7′)-6′-deoxy-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
|
|
β-Neuraminic acid, N-[[2-(9-oxo-10(9H)-acridinyl)ethoxy]acetyl]-, 2-(hydrogen 5′-cytidylate) (9CI)
97%
|
|
|
β-D-xylo-Adenosine, 2′-deoxy-5′-O-phosphonocytidylyl-(3′→5′)-3′-deoxy-3′-fluoro-, ion(3-) (ACI)
97%
|
|
|
β-D-ribo-Heptofuranothymidine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)adenylyl-(3′→5′-7′)-6′-deoxy-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
|
|
β-D-Ribofuranuronamide, 1-deoxy-N-ethyl-1-[6-[(3-oxatricyclo[3.2.1.02,4]oct-6-ylmethyl)amino]-9H-purin-9-yl]- (9CI)
97%
|
